Content
Gentlemen/members of Najran Chamber,
Peace, mercy and blessings of God,,,
Reference to the letter of the Federation of Saudi Chambers No. (43104595) dated (1/11/1443 AH), which indicates that the union received the letter of the Food and Drug General Authority No. (26403/p) dated 10/29/1443 AH, referring to Article 5 of the establishments system And pharmaceutical products issued by Royal Decree No. (M/108) dated (22/8/1441 AH) and what was stipulated in paragraphs (7/12) of the executive regulations of the aforementioned system, which necessitated the fulfillment of licensing conditions in the event of transferring ownership of the factory or any other disposal and the obligation to fulfill Any other conditions or circulars issued by the Authority.
In terms of the authority’s role in ensuring the availability of medicines and achieving pharmaceutical security, the authority has noticed that the availability of medicines and ensuring their continued supply to the Saudi market through family companies that own pharmaceutical factories or their agencies has been affected due to the instability of some of those companies in certain cases such as (the death of the owner, or the president (Executive) and the Authority states the necessity of submitting and informing it of the death of the owner, CEO of the factory or agent, within a maximum period of (30 days) from its date to ensure the continuity of supplying products to the Saudi market, whether imported or manufactured.
We inform you of this for information and briefing.
And accept our regards,,,
